Colorectal Cancer Awareness, Research, Education and Screening (CARES)
Interventional
Allocation: Randomized, Endpoint Classification: Efficacy Study, Intervention Model: Parallel Assignment, Masking: Open Label, Primary Purpose: Screening
Frequency of Immunochemical Fecal Occult Blood Test (I-FOBT) Kit Use
We will measure uptake of I-FOBT as any completed I-FOBT kit by the 12 month post-intervention assessment. That is, the proportion of participants who return a sampled I-FOBT kit by the 12-month assessment (most I-FOBT kits will be returned much sooner) will be estimated for calculation of the primary screening endpoint. I-FOBT use will be compared (CARES vs. SI). It is expected that pairing I-FOBT kits with the CARES toolkit will result in greater CRCS uptake compared to SI plus I-FOBT.
12 Months Post Intervention
No
Clement Gwede, Ph.D., MPH, RN
Principal Investigator
H. Lee Moffitt Cancer Center and Research Institute
United States: Institutional Review Board
MCC-16447
NCT01804179
February 2011
April 2015
Name | Location |
---|---|
H. Lee Moffitt Cancer Center and Research Institute | Tampa, Florida 33612 |